Ginny Mason

921 total citations
24 papers, 398 citations indexed

About

Ginny Mason is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ginny Mason has authored 24 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Ginny Mason's work include HER2/EGFR in Cancer Research (9 papers), Advanced Breast Cancer Therapies (8 papers) and Cancer Treatment and Pharmacology (8 papers). Ginny Mason is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Advanced Breast Cancer Therapies (8 papers) and Cancer Treatment and Pharmacology (8 papers). Ginny Mason collaborates with scholars based in United States, Canada and Portugal. Ginny Mason's co-authors include Gary H. Lyman, Mark R. Somerfield, Jennifer J. Griggs, Lisa A. Newman, M. Elizabeth H. Hammond, Thomas A. Buchholz, Souzan E. El‐Eid, Sara A. Hurvitz, Debu Tripathy and Sandra M. Swain and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Ginny Mason

23 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ginny Mason United States 9 227 176 142 91 78 24 398
Alan Semine United States 10 244 1.1× 161 0.9× 76 0.5× 86 0.9× 39 0.5× 17 506
Fuh Yong Wong Singapore 12 179 0.8× 161 0.9× 90 0.6× 84 0.9× 49 0.6× 49 343
Carlie K. Thompson United States 10 245 1.1× 219 1.2× 67 0.5× 76 0.8× 126 1.6× 18 472
A.B.G. Kwast Netherlands 10 165 0.7× 133 0.8× 51 0.4× 74 0.8× 51 0.7× 13 287
Hyma Schubert Switzerland 9 223 1.0× 146 0.8× 72 0.5× 80 0.9× 53 0.7× 15 445
Jian-Jun He China 8 287 1.3× 193 1.1× 57 0.4× 83 0.9× 44 0.6× 10 437
Rizvan Mamet United States 6 213 0.9× 147 0.8× 240 1.7× 51 0.6× 70 0.9× 9 433
Ángel Martínez-Agulló Spain 9 412 1.8× 358 2.0× 130 0.9× 104 1.1× 59 0.8× 10 553
Zhong-Hua Tang China 7 277 1.2× 182 1.0× 57 0.4× 76 0.8× 37 0.5× 9 415
Christina A. Dilaveri United States 8 179 0.8× 205 1.2× 55 0.4× 116 1.3× 71 0.9× 17 409

Countries citing papers authored by Ginny Mason

Since Specialization
Citations

This map shows the geographic impact of Ginny Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ginny Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ginny Mason more than expected).

Fields of papers citing papers by Ginny Mason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ginny Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ginny Mason. The network helps show where Ginny Mason may publish in the future.

Co-authorship network of co-authors of Ginny Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Ginny Mason. A scholar is included among the top collaborators of Ginny Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ginny Mason. Ginny Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calverley, David C., et al.. (2025). Inconsistent and Inaccurate Cancer Clinical Trial Reporting of Venous and Arterial Thrombotic Events: An Urgent Call to Action. Journal of Clinical Oncology. 43(26). 2851–2855.
2.
Cardoso, Fátima, et al.. (2023). Creating patient-friendly informed consent form (ICF): Insights from global oncology patient insights panels (GOPIPs).. Journal of Clinical Oncology. 41(16_suppl). e24199–e24199. 1 indexed citations
3.
Jagsi, Reshma, Ginny Mason, Beth Overmoyer, et al.. (2022). Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research. Breast Cancer Research and Treatment. 192(2). 235–243. 31 indexed citations
4.
Kaufman, Peter A., Sara A. Hurvitz, Joyce O’Shaughnessy, et al.. (2021). Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry. Breast Cancer Research and Treatment. 188(1). 179–190. 7 indexed citations
5.
Mason, Ginny. (2021). An Interview with Ginny Mason: 20 Years of Kicking Butt and Taking Names. Future Oncology. 17(28). 3679–3684. 1 indexed citations
6.
Mason, Ginny, Beth Overmoyer, Wendy A. Woodward, et al.. (2020). Abstract P6-15-03: Inflammatory breast cancer (IBC) defined: Proposed common diagnostic criteria and scoring - Moving beyond the subjective ‘clinical diagnosis’ of IBC to advance research. Cancer Research. 80(4_Supplement). P6–15. 3 indexed citations
7.
Cobleigh, Melody, Denise A. Yardley, Adam Brufsky, et al.. (2019). Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs. Clinical Cancer Research. 26(5). 1105–1113. 23 indexed citations
8.
Tripathy, Debu, Adam Brufsky, Melody Cobleigh, et al.. (2019). De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry. The Oncologist. 25(2). e214–e222. 45 indexed citations
9.
Sullivan, Sean D., Mark Gorman, Karma L. Kreizenbeck, et al.. (2019). Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care. BMC Medical Research Methodology. 19(1). 27 indexed citations
10.
Hurvitz, Sara A., Joyce O’Shaughnessy, Ginny Mason, et al.. (2018). Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs. Clinical Cancer Research. 25(8). 2433–2441. 63 indexed citations
11.
Cobleigh, Melody, DA Yardley, Adam Brufsky, et al.. (2017). Abstract P5-08-08: Baseline (BL) characteristics, treatment (tx) patterns, and outcomes in patients with hormone receptor (HR)+ vs HR– HER2+ disease from the SystHERs registry. Cancer Research. 77(4_Supplement). P5–8. 1 indexed citations
12.
Mason, Ginny, et al.. (2016). The Effect of an XBOX Kinect Dance Intervention on the Affect of Sedentary University Students. West Indian Medical Journal. 1 indexed citations
13.
Cobleigh, Melody, SA Hurvitz, Joyce O’Shaughnessy, et al.. (2016). Abstract P6-17-01: Central nervous system metastases at diagnosis in patients with HER2+ MBC: Baseline characteristics, HER2-targeted treatments and clinical outcomes from the SystHERs registry. Cancer Research. 76(4_Supplement). P6–17. 1 indexed citations
14.
15.
16.
Hurvitz, Sara A., Mohammad Jahanzeb, Ginny Mason, et al.. (2014). Patient-reported outcomes (PROs) from the systemic therapies for HER2-positive metastatic breast cancer (MBC) registry study (SystHERs): Eliciting the patient experience.. Journal of Clinical Oncology. 32(30_suppl). 286–286. 1 indexed citations
17.
18.
Mason, Ginny & Owen Johnson. (2008). Inflammatory Breast Cancer: Patient Advocate View. Seminars in Oncology. 35(1). 87–91. 4 indexed citations
19.
Mason, Ginny, et al.. (1986). Postanesthesia care of the ophthalmic patient.. PubMed. 1(1). 23–5. 1 indexed citations
20.
Mason, Ginny. (1960). The Present Position Relating to Cancer of the Lung : Symposium by the Thoracic Society. Thorax. 15(1). 1–21. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan Semine Breakdown of academic impact, for papers by Fuh Yong Wong Breakdown of academic impact, for papers by Carlie K. Thompson Breakdown of academic impact, for papers by A.B.G. Kwast Breakdown of academic impact, for papers by Hyma Schubert Breakdown of academic impact, for papers by Jian-Jun He Breakdown of academic impact, for papers by Rizvan Mamet Breakdown of academic impact, for papers by Ángel Martínez-Agulló Breakdown of academic impact, for papers by Zhong-Hua Tang Breakdown of academic impact, for papers by Christina A. Dilaveri
Rankless by CCL
2026